CLEARASIL ULTRA RAPID ACTION  FACE SCRUB- salicylic acid lotion 
Reckitt Benckiser LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clearasil® Ultra Rapid Action
Face Scrub

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne medication

Use

for the treatment of acne

Warnings

For external use only

When using this product

  • avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • limit use to the face and neck

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

water, polyethylene, PPG-15 stearyl ether, glycerin, stearyl alcohol, cetyl betaine, distearyldimonium chloride, sodium lauryl sulfate, cetyl alcohol, alcohol, steareth-21, sodium chloride, behenyl alcohol, synthetic wax, steareth-2, fragrance, lavandula stoechas extract, helichrysum italicum extract, cistus monspeliensis extract, xanthan gum, dimethyl palmitamine, lauryl alcohol, mica, isopropyl alcohol, disodium EDTA, BHT, magnesium nitrate, methylchloroisothiazolinone, magnesium chloride, methylisothiazolinone, sodium sulfate, ferric ferrocyanide, titanium dioxide, FD&C blue no. 1

Questions?

Call 1-866-25-CLEAR (1-866-252-5327).

Distributed by: Reckitt Benckiser LLC
Parsippany, NJ 07054-0224

PRINCIPAL DISPLAY PANEL - 150 mL Tube Label

Clearasil®

ULTRA

Rapid Action
Face Scrub
Salicylic Acid 2% Acne Medication

12
HOURS

Visibly
clearer
skin in as
little as
12 hours

5 FL OZ (150 mL)

PRINCIPAL DISPLAY PANEL - 150 mL Tube Label
CLEARASIL ULTRA RAPID ACTION   FACE SCRUB
salicylic acid lotion
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:63824-305
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid 2 g  in 100 mL
Inactive Ingredients
Ingredient Name Strength
water (UNII: 059QF0KO0R)  
high density polyethylene (UNII: UG00KM4WR7)  
PPG-15 stearyl ether (UNII: 1II18XLS1L)  
glycerin (UNII: PDC6A3C0OX)  
stearyl alcohol (UNII: 2KR89I4H1Y)  
cetyl betaine (UNII: E945X08YA9)  
distearyldimonium chloride (UNII: OM9573ZX3X)  
sodium lauryl sulfate (UNII: 368GB5141J)  
cetyl alcohol (UNII: 936JST6JCN)  
alcohol (UNII: 3K9958V90M)  
steareth-21 (UNII: 53J3F32P58)  
sodium chloride (UNII: 451W47IQ8X)  
docosanol (UNII: 9G1OE216XY)  
steareth-2 (UNII: V56DFE46J5)  
lavandula stoechas flowering top (UNII: 70759G2U6A)  
helichrysum italicum flower (UNII: P62Y550X24)  
xanthan gum (UNII: TTV12P4NEE)  
dimethyl palmitamine (UNII: 5E4QI660PW)  
lauryl alcohol (UNII: 178A96NLP2)  
mica (UNII: V8A1AW0880)  
isopropyl alcohol (UNII: ND2M416302)  
edetate disodium (UNII: 7FLD91C86K)  
butylated hydroxytoluene (UNII: 1P9D0Z171K)  
magnesium nitrate (UNII: 77CBG3UN78)  
methylchloroisothiazolinone (UNII: DEL7T5QRPN)  
magnesium chloride (UNII: 02F3473H9O)  
methylisothiazolinone (UNII: 229D0E1QFA)  
sodium sulfate (UNII: 0YPR65R21J)  
ferric ferrocyanide (UNII: TLE294X33A)  
titanium dioxide (UNII: 15FIX9V2JP)  
FD&C blue no. 1 (UNII: H3R47K3TBD)  
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:63824-305-65 150 mL in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC MONOGRAPH FINAL part333D 09/25/2012
Labeler - Reckitt Benckiser LLC (094405024)

Revised: 9/2012
Document Id: 39fb404a-c1b4-4308-aa17-2aa2673130a5
Set id: e0a3631b-54ca-417e-8168-71f8115fd035
Version: 1
Effective Time: 20120928
 
Reckitt Benckiser LLC